vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Lowe's (LOW). Click either name above to swap in a different company.

Lowe's is the larger business by last-quarter revenue ($20.8B vs $11.5B, roughly 1.8× Abbott Laboratories). Abbott Laboratories runs the higher net margin — 15.5% vs 7.8%, a 7.7% gap on every dollar of revenue. On growth, Abbott Laboratories posted the faster year-over-year revenue change (4.4% vs 3.2%). Abbott Laboratories produced more free cash flow last quarter ($2.6B vs $90.0M). Over the past eight quarters, Abbott Laboratories's revenue compounded faster (7.2% CAGR vs -8.7%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Lowe's Companies, Inc. is an American retail company specializing in home improvement. Headquartered in Mooresville, North Carolina, the company operates a chain of retail stores in the United States. As of October 28, 2022, Lowe's and its related businesses operated 2,181 home improvement and hardware stores in North America.

ABT vs LOW — Head-to-Head

Bigger by revenue
LOW
LOW
1.8× larger
LOW
$20.8B
$11.5B
ABT
Growing faster (revenue YoY)
ABT
ABT
+1.2% gap
ABT
4.4%
3.2%
LOW
Higher net margin
ABT
ABT
7.7% more per $
ABT
15.5%
7.8%
LOW
More free cash flow
ABT
ABT
$2.5B more FCF
ABT
$2.6B
$90.0M
LOW
Faster 2-yr revenue CAGR
ABT
ABT
Annualised
ABT
7.2%
-8.7%
LOW

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ABT
ABT
LOW
LOW
Revenue
$11.5B
$20.8B
Net Profit
$1.8B
$1.6B
Gross Margin
57.0%
34.2%
Operating Margin
19.6%
11.9%
Net Margin
15.5%
7.8%
Revenue YoY
4.4%
3.2%
Net Profit YoY
-80.8%
-4.7%
EPS (diluted)
$1.01
$2.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
LOW
LOW
Q4 25
$11.5B
$20.8B
Q3 25
$11.4B
Q2 25
$11.1B
$20.9B
Q1 25
$10.4B
Q4 24
$11.0B
$20.2B
Q3 24
$10.6B
$23.6B
Q2 24
$10.4B
$21.4B
Q1 24
$10.0B
$18.6B
Net Profit
ABT
ABT
LOW
LOW
Q4 25
$1.8B
$1.6B
Q3 25
$1.6B
Q2 25
$1.8B
$1.6B
Q1 25
$1.3B
Q4 24
$9.2B
$1.7B
Q3 24
$1.6B
$2.4B
Q2 24
$1.3B
$1.8B
Q1 24
$1.2B
$1.0B
Gross Margin
ABT
ABT
LOW
LOW
Q4 25
57.0%
34.2%
Q3 25
55.4%
Q2 25
56.4%
33.4%
Q1 25
56.9%
Q4 24
55.0%
33.7%
Q3 24
55.8%
33.5%
Q2 24
55.6%
33.2%
Q1 24
55.2%
32.4%
Operating Margin
ABT
ABT
LOW
LOW
Q4 25
19.6%
11.9%
Q3 25
18.1%
Q2 25
18.4%
11.9%
Q1 25
16.3%
Q4 24
17.4%
12.6%
Q3 24
17.5%
14.6%
Q2 24
16.1%
12.4%
Q1 24
13.9%
9.1%
Net Margin
ABT
ABT
LOW
LOW
Q4 25
15.5%
7.8%
Q3 25
14.5%
Q2 25
16.0%
7.8%
Q1 25
12.8%
Q4 24
84.1%
8.4%
Q3 24
15.5%
10.1%
Q2 24
12.5%
8.2%
Q1 24
12.3%
5.5%
EPS (diluted)
ABT
ABT
LOW
LOW
Q4 25
$1.01
$2.88
Q3 25
$0.94
Q2 25
$1.01
$2.92
Q1 25
$0.76
Q4 24
$5.26
$2.99
Q3 24
$0.94
$4.17
Q2 24
$0.74
$3.06
Q1 24
$0.70
$1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
LOW
LOW
Cash + ST InvestmentsLiquidity on hand
$8.9B
$1.0B
Total DebtLower is stronger
$12.9B
$37.5B
Stockholders' EquityBook value
$52.1B
$-10.4B
Total Assets
$86.7B
$53.5B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
LOW
LOW
Q4 25
$8.9B
$1.0B
Q3 25
$7.7B
Q2 25
$7.3B
$3.4B
Q1 25
$6.8B
Q4 24
$8.0B
$3.6B
Q3 24
$7.8B
$4.7B
Q2 24
$7.2B
$3.5B
Q1 24
$6.7B
$1.2B
Total Debt
ABT
ABT
LOW
LOW
Q4 25
$12.9B
$37.5B
Q3 25
Q2 25
$30.5B
Q1 25
Q4 24
$14.1B
$32.9B
Q3 24
$34.7B
Q2 24
$34.6B
Q1 24
$35.4B
Stockholders' Equity
ABT
ABT
LOW
LOW
Q4 25
$52.1B
$-10.4B
Q3 25
$51.0B
Q2 25
$50.6B
$-13.3B
Q1 25
$48.8B
Q4 24
$47.7B
$-13.4B
Q3 24
$39.8B
$-13.8B
Q2 24
$39.3B
$-14.6B
Q1 24
$38.8B
$-15.1B
Total Assets
ABT
ABT
LOW
LOW
Q4 25
$86.7B
$53.5B
Q3 25
$84.2B
Q2 25
$84.0B
$45.4B
Q1 25
$81.4B
Q4 24
$81.4B
$44.7B
Q3 24
$74.4B
$44.9B
Q2 24
$73.0B
$45.4B
Q1 24
$72.5B
$41.8B
Debt / Equity
ABT
ABT
LOW
LOW
Q4 25
0.25×
Q3 25
Q2 25
Q1 25
Q4 24
0.30×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
LOW
LOW
Operating Cash FlowLast quarter
$3.3B
$687.0M
Free Cash FlowOCF − Capex
$2.6B
$90.0M
FCF MarginFCF / Revenue
22.9%
0.4%
Capex IntensityCapex / Revenue
6.0%
2.9%
Cash ConversionOCF / Net Profit
1.87×
0.43×
TTM Free Cash FlowTrailing 4 quarters
$7.4B
$6.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
LOW
LOW
Q4 25
$3.3B
$687.0M
Q3 25
$2.8B
Q2 25
$2.0B
$3.4B
Q1 25
$1.4B
Q4 24
$2.9B
$1.3B
Q3 24
$2.7B
$3.2B
Q2 24
$2.0B
$4.3B
Q1 24
$1.0B
$1.1B
Free Cash Flow
ABT
ABT
LOW
LOW
Q4 25
$2.6B
$90.0M
Q3 25
$2.3B
Q2 25
$1.5B
$2.9B
Q1 25
$933.0M
Q4 24
$2.1B
$728.0M
Q3 24
$2.1B
$2.7B
Q2 24
$1.4B
$3.9B
Q1 24
$627.0M
$488.0M
FCF Margin
ABT
ABT
LOW
LOW
Q4 25
22.9%
0.4%
Q3 25
20.2%
Q2 25
13.9%
13.7%
Q1 25
9.0%
Q4 24
19.6%
3.6%
Q3 24
20.2%
11.6%
Q2 24
13.8%
18.2%
Q1 24
6.3%
2.6%
Capex Intensity
ABT
ABT
LOW
LOW
Q4 25
6.0%
2.9%
Q3 25
4.4%
Q2 25
4.5%
2.5%
Q1 25
4.7%
Q4 24
6.6%
2.8%
Q3 24
5.2%
1.8%
Q2 24
5.1%
1.8%
Q1 24
4.0%
3.3%
Cash Conversion
ABT
ABT
LOW
LOW
Q4 25
1.87×
0.43×
Q3 25
1.70×
Q2 25
1.15×
2.06×
Q1 25
1.07×
Q4 24
0.31×
0.77×
Q3 24
1.64×
1.32×
Q2 24
1.51×
2.43×
Q1 24
0.84×
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABT
ABT

Segment breakdown not available.

LOW
LOW

Home Decor$7.8B37%
Building Products$6.9B33%
Hardlines$5.1B25%
Services$753.0M4%
Other$384.0M2%

Related Comparisons